RE:RE:RE:An additional 1,378,843 shares of common stock may be ....TTG, I dont think it matters what school anyone attended, as there is very little with this share transfer in lieu of cash that would be considered standard as a shares for debt would have likely been a more strait forward issue.
Take for instance the statement "An additional 1,378,843 shares of common stock may be issuable to MediPharm to the extent the VWAP of Tilray’s common stock for the five trading days ending on October 9, 2023 declines below $2.3958."
The additional shares that may be issuable were actually more shares than initially transferred to Medipharm in the first issue, so what could possibly trigger an event to recieve more shares than initially receiving in the first place. Was there concerns the shareprice would drop more than 50% in those 5 trading days?
Secondly, according to the first prospectus, the proposed price per unit took place at $2.32, so why is higher price of $2.39 the trigger for additional shares
I think there still may be more to this transaction as alleyesonme has suggested, but with Medipharm tight lipped, we will need to see the upcoming financials to decipher that puzzle or wait for additional disclosure from Tilray.
Stay tuned ..........................